by EmpathiCSubstanceS | Jul 2, 2019 | Addiction, Depression, OCD
A compelling new study has revealed how a mammalian brain can produce an incredibly powerful hallucinogen called DMT. The research shows the psychedelic is endogenously produced in a number of brain regions, including the visual cortex, and spikes in concentrations...
by EmpathiCSubstanceS | Mar 19, 2019 | Depression
A new survey into the anti-depressant qualities of a short-acting psychedelic has reported extraordinarily positive improvements in well-being. The research, led by a team from Johns Hopkins University, suggests the brief duration of action seen in the drug 5-MeO-DMT...
by EmpathiCSubstanceS | Feb 13, 2019 | Depression
A new nasal spray for depression, utilizing a novel drug called esketamine, has passed the last step on its way to final FDA approval. An advisory panel to the Food and Drug Administration (FDA) voted in favor of the new drug’s risk/benefit profile meaning the...
by EmpathiCSubstanceS | Feb 13, 2019 | Depression
The active ingredients of ketamine, a popular club drug, show promise in battling deep despair. In a move that may clear the way for the first new treatment in years for depression, an expert panel recommended on Tuesday that federal regulators approve a nasal spray...
by EmpathiCSubstanceS | Dec 26, 2018 | Depression
The subgranular zone (SGZ) of dentate gyrus (DG) is one of the few regions in which neurogenesis is maintained throughout adulthood. It is believed that newborn neurons in this region encode temporal information about partially overlapping contextual memories. The...
by EmpathiCSubstanceS | Dec 26, 2018 | Depression
Preliminary study suggests that ‘microdoses’ of psychedelics may enhance a person’s creative problem solving abilities The use of minute doses of magic mushrooms and truffles containing psychedelic substances could induce a state of unconstrained...
